America Great HealthAA

America Great Health

0.000100USDD
0.0000000.00%
At close at Jan 10, 20:11 UTC
USD
No trades
See on Supercharts

AAGH fundamentals

Key facts

Market capitalization‪2.12 M‬USD
Founded1997
CEOQing Kun Wang
Websiteaaghus.com
About

America Great Health focuses on protein and peptide small molecular drugs research and development, diagnostic and medical devices with AI cloud computing, cell therapy, and regenerational medicine and supplements manufacturing and sales. Its products and services include proton therapy system, cardio quantum spectrum diagnostic system, smart stethoscope, GOF PSIM pipelines, stem cell, purecell group, and nutrition supplements and personal care. The company was founded in 1997 and is headquartered in Alhambra, CA.

Ownership
‪‪21.19 B‬‬
Free Float shares
‪‪19.05 B‬‬ (89.91%)
Closely held shares
‪‪2.14 B‬‬ (10.09%)
Free Float shares
‪‪19.05 B‬‬ (89.91%)
Closely held shares
‪‪2.14 B‬‬ (10.09%)
Capital structure
No data available
There's currently no data to show about this capital structure.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪2.12 M‬‬
Price to earning ratio (P/E)
Price to sales ratio (P/S)
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
Price to sales ratio (P/S)
Valuation ratios
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪0.00‬
‪500.00‬
‪‪1.00 K‬‬
‪‪1.50 K‬‬
‪‪2.00 K‬‬
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪−1,200.00%‬
‪−950.00%‬
‪−700.00%‬
‪−450.00%‬
‪−200.00%‬
Q1 '24
Q2 '24
Q3 '24
‪‪−300.00 K‬‬
‪‪−200.00 K‬‬
‪‪−100.00 K‬‬
‪0.00‬
‪‪100.00 K‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
No data available
There's currently no revenue data to show for the selected period.

Dividends

Dividend yield, history and sustainability

AAGH does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company

Debt level and coverage
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪‪−700.00 K‬‬
‪0.00‬
‪‪700.00 K‬‬
‪‪1.40 M‬‬
‪‪2.10 M‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
No data available
There's currently no assets and liabilities data to show.